二合一适应性设计用于二分类终点的分析性评价
针对二分类终点,该研究提出无需蒙特卡洛模拟即可精确计算二合一适应性设计一类错误率和把握度的公式,适用于任何二分类终点的统计检验;不同情景下的数值研究显示其二分类终点操作特征与连续或时间事件终点相似,并应用于丙酮酸激酶缺乏症患者临床试验。
要点
- 提出二合一适应性设计二分类终点的精确一类错误率和把握度计算式,无需蒙特卡洛模拟。
- 所提公式适用于任何二分类终点的统计检验。
- 数值研究显示二分类终点操作特征与连续或时间事件终点相似。
核心结论
- 所提公式可精确评价二合一适应性设计二分类终点的一类错误率和把握度,无需蒙特卡洛模拟。
- 不同情景下二分类终点的操作特征与连续或时间事件终点相似。
研究设计与样本
- 方法学研究,提出二合一适应性设计二分类终点一类错误率和把握度的计算公式。
- 在不同情景下进行数值研究,并将公式应用于丙酮酸激酶缺乏症患者的临床试验。
主要发现
- 所提公式可精确计算一类错误率和把握度,无需蒙特卡洛模拟。
- 所提公式适用于任何二分类终点的统计检验。
- 数值研究显示二分类终点操作特征与连续或时间事件终点相似。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To reduce drug development costs and time in therapeutic areas with high unmet medical needs, sponsors are often motivated to accelerate the drug development process, specifically by skipping the Phase 2 trial and starting the Phase 3 trial directly after the Phase 1 trial. To address this need, a novel design called 2-in-1 adaptive design has been proposed recently. This design allows a trial to maintain a small trial or to expand to a large trial adaptively based on decisions made based on the interim analysis. Although several statistical methods have been proposed for the 2-in-1 adaptive design, they specifically emphasize clinical trials with continuous or time-to-event endpoints assuming the normal approximation of the test statistic. Methods for the 2-in-1 adaptive design with binary endpoints are notably lacking. For binary endpoints, some statistical tests do not rely on the normal approximation. Therefore, it is not clear whether the operating characteristics obtained by existing 2-in-1 adaptive design methods in the context of continuous or time-to-event endpoints can be generalized to cases with binary endpoints. For this study, we propose formulas to evaluate the type I error rate and power for the 2-in-1 adaptive design for binary endpoints. Our proposed formulas can evaluate the exact type I error rate and power without using Monte Carlo simulations. Moreover, the proposed formulas are useful for any statistical test of binary endpoints. Numerical investigations under different scenarios demonstrated that the operating characteristics for the 2-in-1 adaptive design with binary endpoints are similar to those with continuous or time-to-event endpoints. We present the application of our proposed formulas to a clinical trial in patients with pyruvate kinase deficiency.
引用
- Homma G, Yoshida T. Analytical Evaluation of the 2-in-1 Adaptive Design for Binary Endpoints. Stat Med. 2026. PMID: 41569393. doi:10.1002/sim.70349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。